Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 9, Number 8—August 2003

Dispatch

NmcA Carbapenem-hydrolyzing Enzyme in Enterobacter cloacae in North America1

Sudha Pottumarthy*, Ellen Smith Moland†, Stefan Juretschko*, Susan R. Swanzy*, Kenneth S. Thomson†, and Thomas R. Fritsche*Comments to Author 
Author affiliations: *University of Washington School of Medicine, Seattle, Washington, USA; †Creighton University Medical Center, Omaha, Nebraska, USA

Main Article

Figure 1

Susceptibility testing of Enterobacter cloacae to carbapenems. Both methods had ill-defined zones of inhibition with inner colonies growing up to the disks or the E-test strips, respectively.

Figure 1. Susceptibility testing of Enterobacter cloacae to carbapenems. Both methods had ill-defined zones of inhibition with inner colonies growing up to the disks or the E-test strips, respectively.

Main Article

1This work was presented in part at the 13th Annual European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, Scotland, 2003.

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO